Celano Michael 4
4 · Larimar Therapeutics, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
Celano Michael
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-09-16$3.15/sh+31,746$100,000→ 31,746 total
Footnotes (1)
- [F1]Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022.